Nature research paper: Evolutionary trajectories of small cell lung cancer under therapy go.nature.com/48Q6Jmx

🫁🧬❔Cologne scientists SFB1399 Department of Translational Genomics unravel the mystery of drug response in small cell lung cancer. They investigated in a long-term research project the development of tumours during the course of treatment. Read more 👇 uni.koeln/S8C93

🔬Join our Department! Apply now for this PostDoc opportunity in cancer genetics, cancer cell biology and cancer immunology. 👩‍🔬🧑‍🔬 SFB1399 Department of Translational Genomics jobs-uk-koeln.de/index.php?ac=j…

First paper from the lab! CDK9 inhibition can overcome resistance to chemotherapy in SCLC and efficiently prolongs survival in an autochthonous #SCLC model. Congratulations Lucas! And thanks to all our collaborators! Check out our study here rdcu.be/dIxdb

New study out from Peltzer Lab. Congratulations to all authors! SFB1399 Nieves Peltzer

Excited to announce Dr. Filippo Beleggia will present on the intriguing interaction between small cell lung cancer and glutamatergic neurons at The Neuron Glia Interface! Join us in Freiburg on Sept 9-11, 2024 or tune in online. #cancerneuroscience #NGI2024 Department of Translational Genomics

Just heard Filippo Beleggio’s compelling talk on the functional synapses between small cell lung cancer and glutamatergic neurons from Department of Translational Genomics! 🧠✨ He made use of a genetic approach using mouse models to uncover these critical interactions. 🔍 #CancerResearch #SCLCancer

Pulmonale Karzinoide: Forschende der #Uniklinik #Köln und der Universität zu Köln entdecken Schlüsselfaktoren für unterschiedliche Krankheitsverläufe bei seltenen Lungentumoren. Die neuen Erkenntnisse könnten in Zukunft zielgerichtetere Therapien ermöglichen. uk-koeln.de/uniklinik-koel…

We are very happy to share our latest collaborative work of the SFB1399 published in Journal of Clinical Oncology TERT Expression and Clinical Outcome in Pulmonary Carcinoids ascopubs.org/doi/10.1200/JC… Congratulations to Lisa Werr and the teams in the Fischer lab and Department of Translational Genomics

University of Cologne Study Reveals that TERT Gene Activation is Linked to Aggressive Pulmonary Carcinoid Tumors - Check the Link for More shorturl.at/djp8L Universität zu Köln #LungCarcinoids #RareDiseases #LungTumors

🔬🫁 Neue Studie zu seltenen Lungentumoren🧬🩺 Forschende der SFB1399 Department of Translational Genomics haben entdeckt, dass die Aktivierung des TERT-Gens entscheidend für den Verlauf von pulmonalen Karzinoiden ist. Sie entscheidet, ob der Tumor harmlos ist oder wächst👇 uni.koeln/83H5D

🔬🫁 New Study on Rare Lung Tumors🧬🩺 Researchers at SFB1399 Department of Translational Genomics have discovered that TERT gene activation is crucial for the progression of pulmonary carcinoids. This gene activation determines whether the tumor remains benign or spreads👇 uni.koeln/42W9Y

TERT Expression and Clinical Outcome in Pulmonary Carcinoids: brnw.ch/21wNvfn Lisa Werr Department of Translational Genomics

🚀 Latest News: 3rd Cologne Conference on Lung Cancer 🗓️We are thrilled to share updates about the 3rd CCLC, happening 26-27 June 2025! 🔗 Check out our website to see the already confirmed speakers – and stay tuned for more to be announced soon! cologne-clc.com

🌟 CCLC 2025 – Registration open🌟 We’re excited to announce that the registration and abstract submission for the 3rd Cologne Conference on Lung Cancer are now live! 📅 Date: June 26-27th 2025 📍 Location: Maritim Hotel, Cologne 🔗 Register here: cologne-clc.com/program-2025/r…

Stellungnahme der Universität zu Köln zur Präsenz auf dem Medienkanal X uni.koeln/WAQAF